Evaxion Biotech A/S (EVAX)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
2. 80
0
0%
$
19.39M Market Cap
- P/E Ratio
- Div Yield
35,100 Volume
-2.08 Eps
$ 2.8
Previous Close Investors:
Want to track EVAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Evaxion Biotech A/S (EVAX) Statistics
Valuation metrics
Market Cap 19.39M
Enterprise value 12.5M
Trailing P/E (ttm) -0.5
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 2.59
Price/Book (mrq) 0.13
Enterprise Value/Revenue 1.67
Enterprise Value/EBITDA -1.26
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 22.95K
Average volume (90 days) 21.53K
Price summary
52-Week low 2.72
52-Week high 12.15
Beta -
50-Day moving average 3.15
200-Day moving average 3.86
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 14 Jan 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.15%
Operating margin -1.16%
Operational effectiveness
Return on assets -0.45%
Return on equity -0.61%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 17.97
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -20.75
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 33.57
Total debt (mrq) -
Total Debt/Equity (mrq) 0.75
Current ratio (mrq) 5.06%
Book value per share (mrq) 22.86
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
